Thiamine Market Report 2026

The thiamine market size has grown strongly in recent years. It will grow from $1.5 billion in 2025 to $1.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing awareness of micronutrient deficiencies, expansion of fortified food programs, rising consumption of dietary supplements, growth of pharmaceutical vitamin formulations, increased use in animal feed nutrition.

The thiamine market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing focus on preventive healthcare nutrition, rising demand for clean-label vitamin ingredients, expansion of nutraceutical product development, growing use of vitamins in functional foods, increasing investments in vitamin manufacturing capacity. Major trends in the forecast period include increasing demand for vitamin fortification in foods, rising use of thiamine in dietary supplements, growing application in animal nutrition, expansion of pharmaceutical-grade vitamin production, enhanced focus on bioavailability and stability improvements.

The rising demand for dietary supplements is expected to drive the growth of the thiamine market in the coming years. Dietary supplements are manufactured products designed to complement a person’s diet and can be consumed in the form of pills, capsules, tablets, powders, or liquids. The growing popularity of dietary supplements is fueled by increased health awareness, a stronger focus on preventive healthcare, and heightened attention to immune system support. Thiamine is included in these supplements to ensure adequate intake of this essential vitamin, which is vital for functions such as energy production, nervous system and heart health, digestion, stress management, and overall metabolic balance. For example, in January 2024, Nutrition Integrated, a UK-based B2B service, reported that since January 2022, the availability of clear protein powder products in Europe rose by 159%, while consumer purchases of clear protein powders in the UK increased by 216% in 2023 compared to 2022. Therefore, the growing demand for dietary supplements is boosting the growth of the thiamine market.

Key companies in the thiamine market are developing innovative products, such as vitamin B1 deficiency infusions, to maintain a competitive edge. Vitamin B1 deficiency infusion involves the therapeutic administration of thiamine directly into the bloodstream via intravenous (IV) delivery. For instance, in June 2023, Lupin Limited, an India-based pharmaceutical company, launched thiamine hydrochloride injection (USP) in multiple-dose vials containing 200 mg/2 mL (100 mg/mL). This injectable solution provides an efficient alternative for patients with oral absorption issues, such as gastrointestinal disorders, or those requiring urgent treatment for severe deficiencies. It offers healthcare providers a reliable method to restore vitamin B1 levels and reduce risks associated with prolonged deficiency.

In April 2023, Koninklijke DSM NV, a Netherlands-based company specializing in nutrition, health, and sustainable living, acquired Firmenich International SA for approximately $18.08 billion. Through this acquisition, Koninklijke DSM NV aims to establish DSM-Firmenich, a leading global entity in the nutrition, health, and beauty sectors. Firmenich SA, based in Switzerland, provides thiamine (Vitamin B1) across various applications to support health and nutrition.

Major companies operating in the thiamine market are BASF SE, Koninklijke DSM N.V., The Nature’s Bounty Co. Ltd., Zhejiang Medicine Co. Ltd., Swanson Health Products Inc., NOW Health Group Inc., Nutricost LLC, Solgar Inc., Tokyo Chemical Industry Co. Ltd., Puritan’s Pride Inc., Aland Nutraceuticals Group, Anhui Tiger Biotech Co. Ltd., Caisson Laboratories Inc., General Nutrition Centers Inc., Huazhong Pharmaceutical Co. Ltd., Xinfa Pharmaceutical Co. Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Acebright Pharmaceuticals Group Co. Ltd., Anhui BBCA Biochemical Co. Ltd., Jiangsu Yibang Pharmaceutical, Nippon Chemical.

Asia-Pacific was the largest region in the thiamine market in 2025. The regions covered in the thiamine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thiamine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the thiamine market by increasing costs of imported raw materials, fermentation substrates, chemical intermediates, and pharmaceutical-grade processing equipment used in vitamin B1 production. Food, pharmaceutical, and animal feed manufacturers in North America and Europe are most affected due to reliance on imported vitamin ingredients, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are raising formulation costs and affecting supply contracts. However, they are also encouraging regional vitamin production, localized sourcing strategies, and investment in domestic fermentation and synthesis facilities.

The thiamine market research report is one of a series of new reports that provides thiamine market statistics, including thiamine industry global market size, regional shares, competitors with a thiamine market share, detailed thiamine market segments, market trends and opportunities, and any further data you may need to thrive in the thiamine industry. This thiamine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Thiamine, also known as Vitamin B1, is an essential water-soluble nutrient in the B-complex group, vital for carbohydrate metabolism and nerve function. It plays a key role in maintaining overall health and proper physiological functions, particularly those related to energy production and neurological health.

The main types of thiamine include thiamine mononitrate, thiamine hydrochloride, and thiamine pyrophosphate. Thiamine mononitrate is a synthetic form of vitamin B1, which is important for human health. Thiamine is available in various forms, such as tablets and capsules, liquids, and powders, and is used in applications including food and beverages, pharmaceuticals, animal feed, dietary supplements, and other areas.

The thiamine market consists of sales of thiamine hydrochloride, thiamine mononitrate, multivitamin supplements, b-complex supplements, and fortified foods. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.